Ascendis Pharma AS (A71) — Net Asset Momentum
Ascendis Pharma AS (A71) recorded a net asset momentum of -54.0% as of December 2025, with net assets of €-162.82 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See shareholders equity of Ascendis Pharma AS for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Ascendis Pharma AS Net Asset Momentum (2016–2025)
This chart tracks Ascendis Pharma AS's year-over-year net asset growth across 10 annual reporting periods from 2016 to 2025. The most recent momentum reading is -54.0%, with net assets of €-162.82 Million EUR as of December 2025. For live market cap and overall valuation, see A71 market cap.
Annual Net Asset History for Ascendis Pharma AS (2016–2025)
The table below shows the complete annual net asset history for Ascendis Pharma AS from 2016 to 2025, covering 10 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Ascendis Pharma AS tangible equity quality to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €-162.82 Million | €1.30 Billion | €1.47 Billion | ▼ -54.0% |
| 2024 | €-105.71 Million | €1.18 Billion | €1.29 Billion | ▲ +27.4% |
| 2023 | €-145.70 Million | €825.59 Million | €971.28 Million | ▼ -155.3% |
| 2022 | €263.35 Million | €1.09 Billion | €826.39 Million | ▼ -70.2% |
| 2021 | €883.63 Million | €1.08 Billion | €201.29 Million | ▲ +5.4% |
| 2020 | €838.71 Million | €979.79 Million | €141.08 Million | ▲ +40.5% |
| 2019 | €597.11 Million | €676.73 Million | €79.62 Million | ▲ +113.2% |
| 2018 | €280.05 Million | €318.97 Million | €38.92 Million | ▲ +49.6% |
| 2017 | €187.21 Million | €210.98 Million | €23.77 Million | ▲ +6.0% |
| 2016 | €176.61 Million | €190.07 Million | €13.46 Million | — |